Skip to content

Insider · CIK 0001216628

Jeryl L Hilleman

director

Files at CUTR (CUTERA INC), SIBN (SI-BONE, Inc.), OMDA (Omada Health, Inc.), NVCR (NovoCure Ltd), HLVX (HilleVax, Inc.). First filing Jun 4, 2025, latest Jun 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $17k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NVCR: NovoCure Ltd

NVCROct 9, 2026 · close 14.58

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
NVCRsell 9
NovoCure Ltd
$17k
999 shares
-15%+17% from low-49% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 5, 2026OMDA
Omada Health, Inc.
AGrant or award
Common Stock
+1,214$0.00$027,8695 d ago
Sep 17, 2025HLVX
HilleVax, Inc.
UTender of shares
Common Stock
-59,224--0Sep 17, 2025
Jul 5, 2025OMDA
Omada Health, Inc.
AGrant or award
Common Stock
+376$0.00$010,112Jul 8, 2025
Jun 23, 2025HLVX
HilleVax, Inc.
AGrant or award
Common Stock
+17,199$0.00$059,224Jun 25, 2025
Jun 5, 2025OMDA
Omada Health, Inc.
AGrant or award
Common Stock
+9,736$0.00$09,736Jun 9, 2025
Jun 5, 2025SIBN
SI-BONE, Inc.
AGrant or award
Common Stock
+8,675$0.00$032,815Jun 6, 2025
Jun 4, 2025NVCR
NovoCure Ltd
AGrant or award
Ordinary Shares
+11,215$0.00$016,806Jun 6, 2025
Jun 4, 2025NVCR
NovoCure Ltd
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 3, 2025NVCR
NovoCure Ltd
SOpen-market sale
Ordinary Shares
-999$17.26$17k5,591Jun 4, 2025
Jun 6, 2024HLVX
HilleVax, Inc.
AGrant or award
Stock Optionderivative
+22,500$0.00$022,500Apr 30, 2025
Oct 24, 2024CUTR
CUTERA INC
AGrant or award
Stock Option (Right to Buy)derivative
+14,673$0.00$040,000Nov 5, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeryl L Hilleman: insider trades and track record | InsiderTell